SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
colorectal
Journals
3
1
journal of community genetics
2
journal of gastrointestinal oncology
3
therapeutic advances in gastroenterology
Research Groups
0
No Research Group Connected
Bibliographies
383
1
Robotic surgery in colorectal cancer: the way forward or a passing fad.
2
Automated endoscopic detection and classification of colorectal polyps using convolutional neural networks.
3
colorectal cancer "methylator phenotype": fact or artifact?
4
The genetics and natural history of hereditary colon cancer.
5
Dodonaea viscosa Jacq. induces cytotoxicity, antiproliferative activity, and cell death in colorectal cancer cells via regulation of caspase 3 and p53
6
Metvan, bis(4,7-Dimethyl-1,10-phenanthroline)sulfatooxidovanadium(IV): DFT and Spectroscopic Study-Antitumor Action on Human Bone and Colorectal Cancer Cell Lines.
7
Multicentre propensity score-matched study of laparoscopic versus open repeat liver resection for colorectal liver metastases.
8
Outcome disparities in colorectal cancer: a SEER-based comparative analysis of racial subgroups.
9
Doneness preferences, meat and meat-derived heterocyclic amines intake, and N-acetyltransferase 2 polymorphisms: association with colorectal adenoma in Japanese Brazilians.
10
Prediction of irinotecan toxicity in metastatic colorectal cancer patients based on machine learning models with pharmacokinetic parameters
11
EGFR signaling in colorectal cancer: a clinical perspective
12
EGFR signaling in colorectal cancer: a clinical perspective
13
EGFR signaling in colorectal cancer: a clinical perspective
14
Hepatopulmonary Fistula in a Colorectal Cancer Patient
15
Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research
16
Impact of Metabolic Syndrome Diagnosis and Its Treatment on Survival of Colorectal Cancer Patients
17
Enhanced Recovery Pathway Improves Colorectal Surgery Outcomes in Private and Safety-Net Settings.
18
Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).
19
Clinicopathologic and Prognostic Differences between Three Different Age Groups (Child/Adolescent, Young Adults, and Adults) of Colorectal Cancer Patients: A Multicentre Study.
20
Transcriptome and DNA Methylome Analysis in a Mouse Model of Diet-Induced Obesity Predicts Increased Risk of Colorectal Cancer
21
En bloc release of MVB-like small extracellular vesicle clusters by colorectal carcinoma cells
22
Implications of Isoprostanes and Matrix Metalloproteinase-7 Having Potential Role in the Development of Colorectal Cancer in Males
23
Determination of effective factors on geographic distribution of the incidence of colorectal cancer in Tehran using geographically weighted Poisson regression model.
24
Gastric environment-stable oral nanocarriers for in situ colorectal cancer therapy.
25
Linking primary care and community organizations to increase colorectal cancer screening rates: the HAPPI project.
26
Ursolic acid suppresses the invasive potential of colorectal cancer cells by regulating the TGF-β1/ZEB1/miR-200c signaling pathway.
27
Investigating the Impact of Geographic Location on Colorectal Cancer Stage at Diagnosis: A National Study of the SEER Cancer Registry.
28
Enhanced Recovery Pathway Improves Colorectal Surgery Outcomes in Private and Safety-Net Settings
29
Surgeon Workload in Colorectal Surgery: Perceived Drivers of Procedural Difficulty
30
SNAIL1 employs β-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation.
31
Rethinking the Re-Prep: Attitudes Toward Noninvasive Colorectal Cancer Screening Tests After Inadequate Bowel Preparation.
32
A novel panel of stool-based DNA biomarkers for early screening of colorectal neoplasms in a Chinese population.
33
Colorectal cancer guidelines seldom include the patient perspective.
34
Integrated Analysis of Oncogenic Networks in Colorectal Cancer Identifies GUCA2A as a Molecular Marker.
35
Computer-aided diagnosis of colorectal polyps using linked color imaging colonoscopy to predict histology
36
Mutation in Colorectal Rhabdoid and Poorly Differentiated Medullary Carcinomas.
37
Dietary changes adopted by Chinese colorectal cancer patients: A qualitative study.
38
The impact of screening on the survival of colorectal cancer in Shanghai, China: a population based study.
39
Evaluation of the usefulness of the simultaneous assay of fecal hemoglobin (Hb) and transferrin (Tf) in colorectal cancer screening - for the establishment of the Hb and Tf two-step cutoff assay (HTTC assay).
40
Patterns of internet and social media use in colorectal surgery.
41
Nanoencapsulated betulinic acid analogue distinctively improves colorectal carcinoma in vitro and in vivo.
42
Patients' information needs and attitudes about post-treatment surveillance for colorectal cancer in the United States: a multi-perspective, mixed methods study.
43
Correction: Griffith, D.M., et al. Novel Improved Synthesis of HSP70 Inhibitor, Pifithrin-μ. In Vitro Synergy Quantification of Pifithrin-μ Combined with Pt Drugs in Prostate and Colorectal Cancer Cells. Molecules 2016, 21, 949
44
Personal and Neighborhood Attributes Associated with Cervical and Colorectal Cancer Screening in an Urban African American Population.
45
Geographical variation and factors associated with colorectal cancer mortality in a universal health care system.
46
Local recurrence and its risk factors after cold snare polypectomy of colorectal polyps.
47
Screening and Stepped Care Targeting Psychological Distress in Patients With Metastatic Colorectal Cancer: The TES Cluster Randomized Trial.
48
Quality of life and colorectal function in Crohn's disease patients that underwent ileocecal resection during childhood.
49
The Future Colorectal Cancer Burden Attributable to Modifiable Behaviors: A Pooled Cohort Study.
50
Prevalence of BRAF gene mutation in samples of primary and metastatic colorectal cancer: A meta-analysis.
51
Protective effect of the “food-microorganism-SCFAs” axis on colorectal cancer: from basic research to practical application
52
Postoperative non-steroidal anti-inflammatory drugs and colorectal anastomotic leakage. NSAIDs and anastomotic leakage.
53
Utilization of the Caprini score in conjunction with thrombodynamic testing reduces the number of unpredicted postoperative venous thromboembolism events in patients with colorectal cancer.
54
Mediterranean diet adherence and risk of colorectal cancer: the prospective Netherlands Cohort Study.
55
Potential early clinical stage colorectal cancer diagnosis using a proteomics blood test panel.
56
DNA Electrochemistry Shows DNMT1 Methyltransferase Hyperactivity in Colorectal Tumors
57
The Colorectal Cancer Screening Programme in the Basque Country: obtaining a good performance by means of professional collaboration
58
Human Colorectal Cancer Infrastructure Constructed by the Glycocalyx.
59
Supportive care needs of patients following treatment for colorectal cancer: risk factors for unmet needs and the association between unmet needs and health-related quality of life-results from the ColoREctal Wellbeing (CREW) study.
60
Preoperative anxiety in Chinese colorectal cancer patients: The role of social support, self-esteem and coping styles
61
Artificial Intelligence-assisted System Improves Endoscopic Identification of Colorectal Neoplasms.
62
Single-cell transcriptional profiling reveals the heterogenicity in colorectal cancer.
63
MicroRNA-193a and taxol combination: A new strategy for treatment of colorectal cancer.
64
Low colorectal cancer survival in the Mountain West state of Nevada: A population-based analysis.
65
Collaborative membrane activity and receptor-dependent tumor cell targeting for precise nanoparticle delivery in CXCR4 colorectal cancer.
66
Predictive biomarkers of colorectal cancer.
67
Association Between Intake of Red and Processed Meat and Survival in Patients With Colorectal Cancer in a Pooled Analysis
68
Exam 1: Association Between Intake of Red and Processed Meat and Survival in Patients With Colorectal Cancer in a Pooled Analysis
69
Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force.
70
Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials
71
Adjuvant chemotherapy in colorectal cancer: mournful, hopeful perpetual motion machine heads to dim light at end of tunnel.
72
Adjuvant Chemotherapy in Colorectal Cancer: Mournful, Hopeful Perpetual Motion Machine Heads to Dim Light at End of Tunnel
73
SWATH-based proteomics reveals processes associated with immune evasion and metastasis in poor prognosis colorectal tumours.
74
Patient-Reported Unmet Needs in Colorectal Cancer Survivors After Treatment for Curative Intent.
75
Pelvic mesh in colorectal pelvic floor surgery-implications of recent developments.
76
First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: The MYPHISMO study protocol (NCT03287427)
77
Design, Synthesis and Biological Activity Evaluation of S-Substituted 1H-5-Mercapto-1,2,4-Triazole Derivatives as Antiproliferative Agents in Colorectal Cancer
78
Synthesis, characterization, anti-proliferative properties and DNA binding of benzochromene derivatives: Increased Bax/Bcl-2 ratio and caspase-dependent apoptosis in colorectal cancer cell line.
79
Phosphodiesterase 4B is an effective therapeutic target in colorectal cancer.
80
Evaluation of MGP gene expression in Colorectal Cancer.
81
Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population.
82
Short-term efficacy of a computer-tailored physical activity intervention for prostate and colorectal cancer patients and survivors: a randomized controlled trial.
83
Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
84
The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.
85
Metformin efficacy and safety for colorectal polyps: a double-blind randomized controlled trial
86
Information needs and information seeking behaviour of patients during follow-up of colorectal cancer in the Netherlands.
87
Colorectal cancer: A paradigmatic model for cancer immunology and immunotherapy
88
Bentonite modified with zinc enhances aflatoxin B adsorption and increase survival of fibroblasts (3T3) and epithelial colorectal adenocarcinoma cells (Caco-2).
89
Klotho-mediated targeting of CCL2 suppresses the induction of colorectal cancer progression by stromal cell senescent microenvironments.
90
Inhibitory Effects of Pectinase-Treated Prunus Mume Fruit Concentrate on Colorectal Cancer Proliferation and Angiogenesis of Endothelial Cells.
91
MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3.
92
Colorectal cancer screening from 45 years of age: Thesis, antithesis and synthesis.
93
Risk of colorectal cancer in users of bisphosphonates: analysis of population-based electronic health records.
94
Comprehensive analysis of colorectal cancer-risk loci and survival outcome: A prognostic role for CDH1 variants.
95
Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor immune cell composition.
96
Effect and mechanism of vitamin D on the development of colorectal cancer based on intestinal flora disorder.
97
The case for philanthropic investment to increase colorectal cancer screening rates: A novel paradigm to address a public health challenge.
98
Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial.
99
Gossypol reduction of tumor growth through ROS-dependent mitochondria pathway in human colorectal carcinoma cells.
100
Development of Deep Learning Algorithm for Detection of Colorectal Cancer in EHR Data.
101
The impact of travel time on colorectal cancer stage at diagnosis in a privately insured population.